{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:28:35Z","timestamp":1786980515298,"version":"build-2736575974"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T00:00:00Z","timestamp":1765584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T00:00:00Z","timestamp":1765584000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lasers Med Sci"],"DOI":"10.1007\/s10103-025-04783-3","type":"journal-article","created":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T04:26:51Z","timestamp":1765600011000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A systematic review of procedural treatment for primary localized cutaneous amyloidosis: focus on efficacy, safety, treatment durability in comparison and combination"],"prefix":"10.1007","volume":"40","author":[{"given":"Nazila","family":"Heidari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parmida","family":"Alaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimia","family":"Ghanavati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Heidari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yekta","family":"Ghane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azadeh","family":"Goodarzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,13]]},"reference":[{"issue":"5","key":"4783_CR1","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s40257-017-0278-9","volume":"18","author":"T Weidner","year":"2017","unstructured":"Weidner T, Illing T, Elsner P (2017) Primary localized cutaneous amyloidosis: a systematic treatment review. Am J Clin Dermatol 18(5):629\u2013642. https:\/\/doi.org\/10.1007\/s40257-017-0278-9","journal-title":"Am J Clin Dermatol"},{"issue":"3","key":"4783_CR2","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1159\/000518948","volume":"238","author":"C Guillet","year":"2022","unstructured":"Guillet C, Steinmann S, Maul JT, Kolm I (2022) Primary localized cutaneous amyloidosis: a retrospective study of an uncommon skin disease in the largest tertiary care center in Switzerland. Dermatology 238(3):579\u2013586. https:\/\/doi.org\/10.1159\/000518948","journal-title":"Dermatology"},{"issue":"1","key":"4783_CR3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.4103\/pigmentinternational.pigmentinternational_","volume":"10","author":"VK Somani","year":"2023","unstructured":"Somani VK, Somani A, Sarkar R (2023) Primary localized cutaneous amyloidosis\u2009\u2013\u2009a review. Pigment Int 10(1):4\u201313. https:\/\/doi.org\/10.4103\/pigmentinternational.pigmentinternational_","journal-title":"Pigment Int"},{"issue":"1","key":"4783_CR4","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1001\/archderm.1972.01620100038010","volume":"106","author":"MH Brownstein","year":"1972","unstructured":"Brownstein MH, Hashimoto K (1972) Macular amyloidosis. Arch Dermatol 106(1):50\u201357","journal-title":"Arch Dermatol"},{"issue":"4","key":"4783_CR5","doi-asserted-by":"publisher","first-page":"515","DOI":"10.5021\/ad.2011.23.4.515","volume":"23","author":"DY Lee","year":"2011","unstructured":"Lee DY, Kim YJ, Lee JY, Kim MK, Yoon TY (2011) Primary localized cutaneous nodular amyloidosis following local trauma. Ann Dermatol 23(4):515\u2013518. https:\/\/doi.org\/10.5021\/ad.2011.23.4.515","journal-title":"Ann Dermatol"},{"issue":"24","key":"4783_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12247672","volume":"12","author":"S Palla","year":"2023","unstructured":"Palla S, Kuroli E, Toth EA, Hidvegi B, Hollo P, Medvecz M (2023) Primary localized cutaneous amyloidosis in Central Europe: a retrospective monocentric study on epidemiology and therapy. J Clin Med 12(24):7672. https:\/\/doi.org\/10.3390\/jcm12247672","journal-title":"J Clin Med"},{"issue":"5 Pt 1","key":"4783_CR7","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/s0190-9622(87)70117-0","volume":"16","author":"MJ Tidman","year":"1987","unstructured":"Tidman MJ, Wells RS, MacDonald DM (1987) Pachyonychia congenita with cutaneous amyloidosis and hyperpigmentation\u2013a distinct variant. J Am Acad Dermatol 16(5 Pt 1):935\u2013940. https:\/\/doi.org\/10.1016\/s0190-9622(87)70117-0","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"4783_CR8","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s40257-021-00620-9","volume":"22","author":"L Hamie","year":"2021","unstructured":"Hamie L, Haddad I, Nasser N, Kurban M, Abbas O (2021) Primary localized cutaneous amyloidosis of keratinocyte origin: an update with emphasis on atypical clinical variants. Am J Clin Dermatol 22(5):667\u2013680. https:\/\/doi.org\/10.1007\/s40257-021-00620-9","journal-title":"Am J Clin Dermatol"},{"issue":"2","key":"4783_CR9","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1046\/j.1365-2265.2003.01782.x","volume":"59","author":"U Verga","year":"2003","unstructured":"Verga U, Fugazzola L, Cambiaghi S, Pritelli C, Alessi E, Cortelazzi D et al (2003) Frequent association between MEN 2A and cutaneous lichen amyloidosis. Clin Endocrinol 59(2):156\u201361. https:\/\/doi.org\/10.1046\/j.1365-2265.2003.01782.x","journal-title":"Clin Endocrinol"},{"issue":"2","key":"4783_CR10","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/j.1440-0960.2008.00434.x","volume":"49","author":"JY Choi","year":"2008","unstructured":"Choi JY, Sippe J, Lee S (2008) Acitretin for lichen amyloidosus. Australas J Dermatol 49(2):109\u2013113. https:\/\/doi.org\/10.1111\/j.1440-0960.2008.00434.x","journal-title":"Australas J Dermatol"},{"issue":"7","key":"4783_CR11","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1046\/j.1365-4362.1999.00714.x","volume":"38","author":"BP Khoo","year":"1999","unstructured":"Khoo BP, Tay YK, Goh CL (1999) Calcipotriol ointment vs. betamethasone 17-valerate ointment in the treatment of lichen amyloidosis. Int J Dermatol 38(7):539\u2013541. https:\/\/doi.org\/10.1046\/j.1365-4362.1999.00714.x","journal-title":"Int J Dermatol"},{"issue":"6","key":"4783_CR12","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1007\/s10103-013-1431-1","volume":"28","author":"R Hegazy","year":"2013","unstructured":"Hegazy R (2013) Laser Florence 2013. Lasers Med Sci 28(6):1405\u20131433. https:\/\/doi.org\/10.1007\/s10103-013-1431-1","journal-title":"Lasers Med Sci"},{"issue":"3","key":"4783_CR13","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/lsm.22338","volume":"47","author":"R Panchaprateep","year":"2015","unstructured":"Panchaprateep R, Tusgate S, Munavalli GS, Noppakun N (2015) Fractional 1,550 Nm Ytterbium\/Erbium fiber laser in the treatment of lichen amyloidosis: clinical and histological study. Lasers Surg Med 47(3):222\u2013230. https:\/\/doi.org\/10.1002\/lsm.22338","journal-title":"Lasers Surg Med"},{"issue":"5","key":"4783_CR14","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1007\/s10103-020-02954-y","volume":"35","author":"MA Nilforoushzadeh","year":"2020","unstructured":"Nilforoushzadeh MA, Zolghadr S, Heidari-Kharaji M, Alavi S, Mahmoudbeyk M (2020) A comparative study of the efficacy of fractional neodymium-doped yttrium aluminum Garnet (Nd:YAG) laser therapy alone and in combination with erbium:yag laser therapy: tracing and objective measurement of melanin index in macular amyloidosis. Lasers Med Sci 35(5):1171\u20131177. https:\/\/doi.org\/10.1007\/s10103-020-02954-y","journal-title":"Lasers Med Sci"},{"issue":"1","key":"4783_CR15","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1034\/j.1600-0781.2001.017001042.x","volume":"17","author":"AG Jin","year":"2001","unstructured":"Jin AG, Por A, Wee LK, Kai CK, Leok GC (2001) Comparative study of phototherapy (UVB) vs. photochemotherapy (PUVA) vs. topical steroids in the treatment of primary cutaneous lichen amyloidosis. Photodermatol Photoimmunol Photomed 17(1):42\u201343. https:\/\/doi.org\/10.1034\/j.1600-0781.2001.017001042.x","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"1","key":"4783_CR16","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13643-021-01626-4","volume":"10","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev 10(1):89. https:\/\/doi.org\/10.1186\/s13643-021-01626-4","journal-title":"Syst Rev"},{"key":"4783_CR17","unstructured":"National Heart L, Institute B (2014) Quality Assessment of Clinical trials } [https:\/\/www.nhlbi.nih.gov\/health-topics\/study-quality-assessment-tools]"},{"key":"4783_CR18","unstructured":"National Heart, L, and Blood Institute (2014). Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies https:\/\/www.nhlbi.nih.gov\/health-topics\/study-quality-assessment-tools]"},{"key":"4783_CR19","unstructured":"National Heart L, and Blood Institute (2014). Quality Assessment Tool for Before-After (Pre-Post) Studies With No Control Group . [https:\/\/www.nhlbi.nih.gov\/health-topics\/study-quality-assessment-tools]"},{"issue":"4","key":"4783_CR20","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/j.1468-3083.2007.02473.x","volume":"22","author":"N Ostovari","year":"2008","unstructured":"Ostovari N, Mohtasham N, Oadras MS, Malekzad F (2008) 532-nm and 1064-nm Q-switched nd:yag laser therapy for reduction of pigmentation in macular amyloidosis patches. J Eur Acad Dermatol Venereol 22(4):442\u2013446. https:\/\/doi.org\/10.1111\/j.1468-3083.2007.02473.x","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"4783_CR21","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/lsm.22361","volume":"47","author":"SM Esmat","year":"2015","unstructured":"Esmat SM, Fawzi MM, Gawdat HI, Ali HS, Sayed SS (2015) Efficacy of different modes of fractional CO2 laser in the treatment of primary cutaneous amyloidosis: a randomized clinical trial. Lasers Surg Med 47(5):388\u2013395. https:\/\/doi.org\/10.1002\/lsm.22361","journal-title":"Lasers Surg Med"},{"issue":"4","key":"4783_CR22","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s10103-018-2457-1","volume":"33","author":"RM Sobhi","year":"2018","unstructured":"Sobhi RM, Sharaoui I, El Nabarawy EA, El Nemr Esmail RS, Hegazy RA, Aref DHF (2018) Comparative study of fractional CO(2) laser and fractional CO(2) laser-assisted drug delivery of topical steroid and topical vitamin C in macular amyloidosis. Lasers Med Sci 33(4):909\u201316. https:\/\/doi.org\/10.1007\/s10103-018-2457-1","journal-title":"Lasers Med Sci"},{"key":"4783_CR23","first-page":"24","volume":"11","author":"J Kaur","year":"2021","unstructured":"Kaur J, Kaur T (2021) An advanced study on efficacy of high fluence Q-Switched nd: YAG laser in macular amyloidosis. Highlights Med Med Sci 11:24\u201331","journal-title":"Highlights Med Med Sci"},{"issue":"4","key":"4783_CR24","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1002\/lsm.23313","volume":"53","author":"MMT Fawzi","year":"2021","unstructured":"Fawzi MMT, Gawdat HI, Mahmoud SB, El-Hawary MS, Rashed LA, Esmat SM (2021) Fractional carbon dioxide laser is effective in amelioration of pruritus in primary cutaneous amyloidosis: a clinical and biochemical study. Lasers Surg Med 53(4):482\u2013487. https:\/\/doi.org\/10.1002\/lsm.23313","journal-title":"Lasers Surg Med"},{"issue":"3","key":"4783_CR25","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1080\/09546634.2019.1655136","volume":"32","author":"Y Nahidi","year":"2021","unstructured":"Nahidi Y, Delghandi SR, Kiafar B, Saki A (2021) The therapeutic effects of 1540-nm nonablative fractional erbium laser on macular amyloidosis: a randomized clinical trial. J Dermatolog Treat 32(3):340\u2013344. https:\/\/doi.org\/10.1080\/09546634.2019.1655136","journal-title":"J Dermatolog Treat"},{"issue":"2","key":"4783_CR26","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1080\/09546634.2019.1654071","volume":"32","author":"M Radmanesh","year":"2021","unstructured":"Radmanesh M, Ghanatir F, Radmanesh R (2021) Comparing the efficacy of pulsed dye laser, Q-Switched Nd-YAG, CO2, and combined CO(2) and Q-Switched Nd-YAG lasers for the treatment of cutaneous macular amyloidosis. J Dermatolog Treat 32(2):258\u201360. https:\/\/doi.org\/10.1080\/09546634.2019.1654071","journal-title":"J Dermatolog Treat"},{"issue":"5","key":"4783_CR27","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1007\/s10103-020-03188-8","volume":"36","author":"M Wang","year":"2021","unstructured":"Wang M, Lin Y, Wu W, Yu Y, Liu X, Gao X et al (2021) Treatment of lichen amyloidosis with fractional CO(2) laser and topical steroid: a preliminary study of 10 cases. Lasers Med Sci 36(5):1123\u20137. https:\/\/doi.org\/10.1007\/s10103-020-03188-8","journal-title":"Lasers Med Sci"},{"issue":"3","key":"4783_CR28","doi-asserted-by":"publisher","first-page":"162","DOI":"10.18231\/j.ijced.2022.034","volume":"8","author":"S S","year":"2022","unstructured":"S S, B L, K K (2022) A comparative study of 30% trichloroacetic acid chemical peel with Q switched Nd-YAG laser 1064nm in the treatment of Macular amyloidosis. IP Indian J Clin Exp Dermatol 8(3):162\u20138. https:\/\/doi.org\/10.18231\/j.ijced.2022.034","journal-title":"IP Indian J Clin Exp Dermatol"},{"issue":"1","key":"4783_CR29","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4103\/JCAS.JCAS_55_23","volume":"17","author":"A Vaghasia","year":"2024","unstructured":"Vaghasia A, Kamat S, Kansara K, Dharmender J, Shah BJ (2024) A prospective comparative study of efficacy and safety of 15% trichloroacetic acid peel, 35% glycolic acid peel and Q-switched Nd-YAG laser in patients of macular amyloidosis. J Cutan Aesthet Surg 17(1):41\u201349. https:\/\/doi.org\/10.4103\/JCAS.JCAS_55_23","journal-title":"J Cutan Aesthet Surg"},{"issue":"1","key":"4783_CR30","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s10103-023-03965-1","volume":"39","author":"F Mokhtari","year":"2024","unstructured":"Mokhtari F, Yazdanpanah M, Iraji F, Asilian A, Siadat A, Tavakolifard N (2024) Evaluation and comparison of Q-switched nd: YAG laser 1064 Nm and er: YAG laser 2940 Nm in the treatment of macular amyloidosis. Lasers Med Sci 39(1):22. https:\/\/doi.org\/10.1007\/s10103-023-03965-1","journal-title":"Lasers Med Sci"},{"issue":"12","key":"4783_CR31","doi-asserted-by":"publisher","first-page":"3968","DOI":"10.1111\/jocd.16517","volume":"23","author":"M Gheisari","year":"2024","unstructured":"Gheisari M, Ghalamkarpour F, Moslemi Haghighi S, Zaresharifi S, Dadkhahfar S, Al-Zubaidi N et al (2024) The effect of topical tranexamic acid with micro-needling and micro-needling alone in treatment of macular amyloidosis. J Cosmet Dermatol 23(12):3968\u201373. https:\/\/doi.org\/10.1111\/jocd.16517","journal-title":"J Cosmet Dermatol"},{"issue":"8","key":"4783_CR32","doi-asserted-by":"publisher","first-page":"WC01","DOI":"10.7860\/JCDR\/2017\/24273.10334","volume":"11","author":"K Mehrotra","year":"2017","unstructured":"Mehrotra K, Dewan R, Kumar JV, Dewan A (2017) Primary cutaneous amyloidosis: a clinical, histopathological and immunofluorescence study. J Clin Diagn Res 11(8):WC01-WC5. https:\/\/doi.org\/10.7860\/JCDR\/2017\/24273.10334","journal-title":"J Clin Diagn Res"},{"issue":"2","key":"4783_CR33","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s10787-024-01436-9","volume":"32","author":"MA Nilforoushzadeh","year":"2024","unstructured":"Nilforoushzadeh MA, Heidari N, Ghane Y, Heidari A, Hajikarim-Hamedani A, Hosseini S et al (2024) A systematic review of interleukin-31 inhibitors in the treatment of prurigo nodularis. Inflammopharmacology 32(2):991\u20131003. https:\/\/doi.org\/10.1007\/s10787-024-01436-9","journal-title":"Inflammopharmacology"},{"issue":"6","key":"4783_CR34","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1111\/bjd.14391","volume":"174","author":"HL Tey","year":"2016","unstructured":"Tey HL, Cao T, Nattkemper LA, Tan VW, Pramono ZA, Yosipovitch G (2016) Pathophysiology of pruritus in primary localized cutaneous amyloidosis. Br J Dermatol 174(6):1345\u20131350. https:\/\/doi.org\/10.1111\/bjd.14391","journal-title":"Br J Dermatol"},{"issue":"3","key":"4783_CR35","doi-asserted-by":"publisher","first-page":"166","DOI":"10.4103\/pigmentinternational.pigmentinternational_","volume":"9","author":"AP Kombettu","year":"2022","unstructured":"Kombettu AP, Gurumurthy C, Rangappa V, Shastry V (2022) Frictional melanosis and macular amyloidosis \u2013 exploring the link. Pigment International 9(3):166\u201375. https:\/\/doi.org\/10.4103\/pigmentinternational.pigmentinternational_","journal-title":"Pigment International"},{"issue":"2","key":"4783_CR36","first-page":"101","volume":"64","author":"WJ Wang","year":"2001","unstructured":"Wang WJ, Chang YT, Huang CY, Lee DD (2001) Clinical and histopathological characteristics of primary cutaneous amyloidosis in 794 Chinese patients. Zhonghua Yi Xue Za Zhi (Taipei) 64(2):101\u2013107","journal-title":"Zhonghua Yi Xue Za Zhi (Taipei)"},{"issue":"3","key":"4783_CR37","doi-asserted-by":"publisher","first-page":"e56248","DOI":"10.7759\/cureus.56248","volume":"16","author":"AM Gakkhar At, Mehendale","year":"2024","unstructured":"Gakkhar At, Mehendale AM, Mehendale S (2024) An interesting case of macular amyloidosis with no significant etiology. Cureus 16(3):e56248. https:\/\/doi.org\/10.7759\/cureus.56248","journal-title":"Cureus"},{"issue":"2","key":"4783_CR38","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/dth.12057","volume":"27","author":"O Norisugi","year":"2014","unstructured":"Norisugi O, Yamakoshi T, Shimizu T (2014) Successful treatment of lichen amyloidosis using a CO2 surgical laser. Dermatol Ther 27(2):71\u201373. https:\/\/doi.org\/10.1111\/dth.12057","journal-title":"Dermatol Ther"},{"issue":"1","key":"4783_CR39","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/dth.12023","volume":"27","author":"YW Yew","year":"2014","unstructured":"Yew YW, Tey HL (2014) Itch in familial lichen amyloidosis: effective treatment with amitriptyline in two cases. Dermatol Ther 27(1):12\u201315. https:\/\/doi.org\/10.1111\/dth.12023","journal-title":"Dermatol Ther"},{"issue":"1","key":"4783_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14764172.2017.1406605","volume":"21","author":"M Korbi","year":"2019","unstructured":"Korbi M, Akkari H, Soua Y, Mohamed M, Youssef M, Belhajdali H et al (2019) Lichen amyloidosis successfully treated with fractional ablative laser CO(2): a new alternative therapeutic. J Cosmet Laser Ther 21(1):1\u20133. https:\/\/doi.org\/10.1080\/14764172.2017.1406605","journal-title":"J Cosmet Laser Ther"},{"issue":"3","key":"4783_CR41","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13278","volume":"33","author":"F Jowkar","year":"2020","unstructured":"Jowkar F, Kahnooj MH, Aslani FS, Parvizi MM (2020) Clinicopathological evaluation of patients with rippled pattern pigmentation of the skin: a single-center study. Dermatol Ther 33(3):e13278. https:\/\/doi.org\/10.1111\/dth.13278","journal-title":"Dermatol Ther"},{"issue":"4","key":"4783_CR42","doi-asserted-by":"publisher","first-page":"244","DOI":"10.4103\/2229-5178.185468","volume":"7","author":"A Singh","year":"2016","unstructured":"Singh A, Yadav S (2016) Microneedling: advances and widening horizons. Indian Dermatol Online J 7(4):244\u2013254. https:\/\/doi.org\/10.4103\/2229-5178.185468","journal-title":"Indian Dermatol Online J"}],"container-title":["Lasers in Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-025-04783-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10103-025-04783-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-025-04783-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T07:22:22Z","timestamp":1771399342000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10103-025-04783-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,13]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4783"],"URL":"https:\/\/doi.org\/10.1007\/s10103-025-04783-3","relation":{},"ISSN":["1435-604X"],"issn-type":[{"value":"1435-604X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,13]]},"assertion":[{"value":"2 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"524"}}